A camera mounted on a tripod set up beside a window

Social and video for source markets: earning trust across a border

16 min read

Social media for international patients is about earning trust from families who cannot verify anything about your hospital in person. Doctor explainers, films about the process and the people, and an honest explanation of estimates do most of the work. Subtitle everything properly, staff the comments in the market’s language, route every conversation to one official number, and judge the effort by arrivals rather than reach.

A woman in Nairobi has been told her husband needs a procedure that cannot be done locally. Someone mentions India. Before she writes to a single hospital, she will spend several evenings watching. A video of a doctor explaining the procedure. A clip of a corridor and a room. A comment thread under a post where somebody says they went last year. A reel in which a coordinator introduces herself. Only then does she send a message.

That watching period is where the decision is really made, and most Indian hospitals are absent from it. We publish for our own city, in our own idiom, about our own achievements, and then wonder why an enquiry from abroad arrives cold and price led. Social media for international patients is not a version of the domestic content calendar with subtitles added. It is a different job: earning trust from a stranger, across a border, who has no way to verify anything you say.

The good news is that the content which works is cheap and unglamorous. It is not a film crew. It is a doctor with a decent microphone, a coordinator with a phone, and someone who knows what families from that market are actually afraid of.

Why a family abroad watches before they write

At home, trust has many sources: a neighbour who was treated there, a family doctor’s recommendation, the building you drive past, the reputation of the brand. A family abroad has almost none of these. They have a name given to them by a relative or a referring doctor, and whatever the internet shows.

So they look for evidence of three things. That the hospital exists as a serious institution rather than a broker with a website. That the doctor is real and has done this operation many times. And that people like them have been there and were treated decently. Video does all three faster than text, which is why it dominates the early stage of medical value travel research in most source markets.

The second reason is language. A family who reads English slowly will happily watch a doctor speak, especially with subtitles in their own language. Video lowers the effort of understanding, and understanding is what the family is short of.

There is a third reason, which operators underrate. The person watching is often not the patient. It is a son in a third country who will pay, a daughter who will travel as the attendant, a cousin who has been asked to check the hospital out. They are watching on behalf of someone else, which makes them more sceptical and more thorough than a domestic enquirer would be. They will read comments, look for the doctor elsewhere on the web, and notice if the hospital name on your channel does not match the one on your website.

Where social media for international patients actually happens

Do not assume your domestic channel mix. In several African and South Asian source markets, a large, older social network is still where community conversation lives, and the relevant activity happens inside groups rather than on pages. In the Gulf and in parts of Central Asia, short video and image led platforms carry more weight. Across almost all of them, the long form video platform is where the actual research happens, because a family will watch ten minutes of a doctor explaining something if it is the thing keeping them awake.

There is also a layer you cannot post into: private groups of people from one country living in another, where a name is passed around and a hospital is vouched for or warned about. You will never control that. You can influence it, by making sure the people who do have good experiences have something to forward, and by making the public information easy to check.

Work this out per market before spending anything. The same exercise that tells you what people type, described in international patient search behaviour, will tell you where they watch. Ask arriving patients directly where they first saw the hospital. Their answers are more reliable than a platform’s audience estimate.

The formats that travel across a border

A small number of formats do nearly all the work. The first is a doctor explaining a condition and its treatment in plain language, looking at the camera, without a hospital advertisement wrapped around it. Not a case presentation. The explanation a good consultant gives a frightened family in the room.

The second is the process film. What happens after you send your reports. How an estimate is produced. What the airport pickup looks like. Where an attendant sleeps and what they will eat. What the ward looks like at night. These are dull to make and enormously reassuring to watch, because they answer the question nobody asks out loud: what will happen to us when we land.

The third is the people. The coordinator who will answer the message, saying her name and which languages she speaks. The interpreter. The person at the international desk. A family abroad is trying to find out whether a human being will take responsibility for them, and a face with a name answers that better than any statement about patient centred care.

The fourth is the honest answer to the money question. You cannot publish prices and should not. You can explain how an estimate is built, what is inside it, what can change it, and how fast it comes. A short video that treats the family as adults on this subject does more for trust than anything else you will publish.

What does not travel: awards ceremonies, equipment announcements, doctors’ days, founder messages, and anything that requires the viewer to already care about your brand. Our domestic calendars are full of these. They are invisible abroad. The judgement about what belongs on a hospital’s public feed at all is covered in hospital social media marketing when the subject is health, and the bar is higher, not lower, when the audience cannot verify you.

Subtitles, dubbing and the accent question

Subtitle everything. Most of this is watched with the sound off in the first few seconds, and a family reading in their second language needs the words on screen. Burned in subtitles survive being downloaded and forwarded, which is how a lot of this content actually spreads.

Translate the subtitles properly. Automatic captioning mangles medical terms and proper nouns, and a mistranslated clinical word in your own video is a real problem. Have a native speaker check them, the same way you would check a page.

On accents: Indian English is understood in most source markets, and there is no reason to apologise for it. What genuinely helps is speaking slowly, using short sentences, avoiding idiom, and not using abbreviations that mean nothing outside our system. Where you have a doctor or coordinator who speaks the market’s language, use them, and let them record directly in that language rather than dubbing over English.

Community: the group, the comment and the private message

Publishing is the easy half. The response is where the trust is won or lost, and it needs to be staffed. Comments under a video about a serious condition will include people describing their own case and asking what they should do. The hospital must answer, and must not answer clinically. The pattern that works is a warm acknowledgement, a clear statement that a doctor needs to see the reports before anyone can comment, and an invitation to move to a private channel.

That invitation should land in the same place as everything else. A comment that leads to a private message that leads to a personal number is how cases get lost, so the route should be to the one official messaging number, which is why social and WhatsApp for international enquiries have to be designed as one system.

Moderation needs a policy written before you need it: what you delete, what you hide, what you never delete. Deleting a complaint from a family abroad in a market where everyone talks to each other is expensive. Answering it publicly and moving it to private is usually the right move.

Creators and partnerships, handled carefully

Working with a creator in a source market can shortcut years of audience building. It can also create a problem you cannot reach across a border. A few rules I would not bend. Nobody promises outcomes or compares countries. Paid relationships are disclosed. The creator does not give medical advice, and no content implies that the hospital treats individual cases from their audience differently.

Prefer people who already talk about health or diaspora life honestly, over the largest audience available. Give them access to something real, a doctor to interview or a process to film, rather than a script. Audiences in these markets are quick to identify an advertisement dressed as a story, and the reaction travels.

The same caution applies to facilitators who want to use your brand in their own content. Agree in writing what they may and may not say, and check periodically. Your name is on it either way.

Paid distribution without burning the budget

Organic reach across a border is slow, so some paid distribution is usually necessary. Keep it narrow and patient. Target one country and one language at a time. Promote the content that answers questions rather than the content that announces things. Send the traffic to the country page for that market, not the homepage, which is the practical reason country landing pages should exist before the campaign does.

Two traps. The first is optimising for cheap enquiries, which in these markets buys you a large number of messages from people who will never travel, and exhausts a desk that could have been serving real cases. The second is judging a market too early: the decision cycle here runs for months, so a campaign assessed after a few weeks will always look like a failure.

Diaspora targeting deserves separate thought. Often the person who chooses the hospital is a son or daughter living in a third country, and reaching them where they live, in English, is a different campaign from reaching the patient at home. Treat them as their own audience with their own content, not as an afterthought.

Consent and compliance when the patient lives elsewhere

Patient content is the most persuasive thing you can publish and the easiest to get wrong. Consent must be informed, in a language the person reads, specific about where the content will appear, in which countries, for how long, and how to withdraw it. Consent given in a corridor before a flight home is not consent for a campaign running two years later in their own town. The full argument sits in the work on patient stories with consent across borders.

Alongside consent, keep to the rules that apply to any healthcare advertising here: no claims of superiority, no outcome promises, no before and after imagery that implies a guarantee, no testimonials that function as clinical claims, and care with anything that could be read as soliciting patients in a jurisdiction with its own advertising rules. When in doubt, publish the explanation rather than the result.

A ninety day plan for one market

Pick a single source market where patients already arrive. Spend the first two weeks listening: ask arriving families where they first saw you, read the comments on whatever you have already published, and find the groups and creators that market actually watches. Then produce a small, fixed set: three doctor explainers on the specialties that genuinely travel from there, one process film, one film introducing the desk and the languages it speaks, and one honest piece about how estimates work. Subtitle all of it properly.

Publish on a predictable rhythm, staff the comments with someone who can answer in the language, and route every conversation to the one official number. Put a small, narrow budget behind the two pieces that perform best organically, pointed at the country page. Use a hospital social media checklist to keep the governance side honest while you move quickly.

At the end of the quarter, judge it on the right things: whether enquiries from that market arrive warmer and better informed, whether families mention the videos, and whether the desk is spending less time explaining basics. Reach and follower counts will tell you almost nothing, and the whole point of treating the international patient funnel as a digital product is that you measure what happens to the family, not what happens to the post.

Questions people ask

What is social media for international patients?

It is the use of social and video platforms to build trust with families in source markets who are considering treatment abroad and have no way to verify a hospital themselves. It covers doctor explainers, films about the process and the people, community management in the family’s language, careful creator partnerships, and narrow paid distribution pointed at a country page rather than the homepage.

How is this different from our domestic social media?

The audience cannot verify anything. At home, trust comes from neighbours, referring doctors and the building itself. Abroad, it comes almost entirely from what can be watched and read. That shifts content away from announcements and awards towards explanation, process and people, and it makes language, subtitles and staffed comment handling central rather than optional.

Which platforms should we be on?

Work it out market by market rather than copying your domestic mix. Long form video carries most of the research in almost every source market. Community conversation sits on different networks depending on the country, often inside private groups you cannot post into. The most reliable research is asking arriving patients where they first saw the hospital, because platform audience estimates are unreliable at this scale.

What content actually works?

Doctors explaining a condition in plain language, films showing what happens after reports are sent, the arrival and the ward, the coordinators and interpreters introducing themselves by name and language, and an honest explanation of how an estimate is produced. What does not work is anything requiring the viewer to already care about your brand: awards, equipment announcements and internal celebrations.

Do we need to translate or dub everything?

Subtitle everything, and have the subtitles translated by a person rather than generated automatically, because medical terms and names get mangled. Dubbing is rarely worth it. Where you have a doctor or coordinator who speaks the market’s language, let them record directly in that language instead. Indian English is widely understood; speaking slowly and avoiding idiom and abbreviations helps far more than accent coaching.

How do we handle clinical questions in the comments?

With a warm acknowledgement, a clear statement that a doctor must see the reports before anyone can comment on an individual case, and an invitation into a private channel. Never a clinical opinion, however general it sounds. Staff the comments with someone who can answer in the language, and route every conversation to the single official messaging number rather than a personal one.

Is working with creators in source markets safe?

It can be, with rules set in writing first. No outcome promises, no comparisons between countries, no medical advice from the creator, and clear disclosure of paid relationships. Prefer people who already talk about health or diaspora life credibly over the largest audience available, and give them access to something real to film rather than a script, because audiences recognise a staged advertisement quickly.

How should we spend paid budget here?

Narrowly and patiently. One country and one language at a time, promoting the content that answers questions rather than the content that announces things, and sending traffic to that market’s country page. Avoid optimising for cheap enquiries, which fills the desk with messages from people who will never travel, and avoid judging a market before a full decision cycle has passed.

What consent do we need for patient stories?

Informed consent in a language the person reads, specific about where the content will appear, in which countries, for how long and how to withdraw it, recorded properly rather than agreed verbally. Consent obtained in a corridor before a flight home does not cover a campaign running years later in the patient’s own town. Withdrawal must be honoured across every platform, including reposts.

What are the compliance limits?

The rules that apply to healthcare advertising here still apply, and the destination country may have its own. No claims of superiority, no outcome promises, no imagery implying a guarantee, and no testimonial that functions as a clinical claim. Do not state visa, eligibility or scheme rules as current fact. When in doubt, publish the explanation of a process rather than the result of a case.

Who should own this internally?

Brand or digital should own production and the calendar, the international desk should own language cover and comment handling, and a named clinician should review anything describing treatment. It fails when the social team publishes in languages nobody at the desk can answer in, or when the desk builds a following on a personal account that leaves when the person does.

How long before it shows results?

Plan a quarter to build the first set of content and a second quarter before enquiry quality visibly changes, because the decision cycle across a border is long. The first sign is qualitative: families mention what they watched, arrive with reports already prepared, and ask about the process rather than whether you treat the condition at all.

How much production effort does this need?

Less than teams expect. A quiet room, good sound, a phone or a modest camera, and a doctor who can explain things clearly will outperform a produced film. The real effort goes into subtitles, translation review, clinical sign off and staffing the comments. Budget for those rather than for production value, which the audience does not reward here.

How do we measure it?

Not by reach or followers. Track enquiries and arrivals by source market, the share of enquiries that mention your content, and whether the desk spends less time explaining basics. Watch comment response times in the market’s own daytime. Judge the whole thing at the level of the funnel, since content that raises enquiry volume but not arrivals is usually promising something the hospital cannot deliver.

Free download

Get the Hospital Digital Growth Audit

A 25-point self-assessment across AI operations, growth & CRM, launches, leadership, and PR. Confirm your email and it arrives in your inbox, along with the full Tools & Checklists set. Occasional notes after; unsubscribe anytime.